Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Conde

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
The European Respiratory Journal|September 7, 2010
Composite anatomical-clinical-molecular prognostic model in non-small cell lung cancerA López-Encuentra, F López-Ríos, E Conde, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|August 7, 2013
Addressing key ecological questions to support policy-making in BrazilR M Almeida, V G Pinto, M M Castro, et al.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experienceJ Rodriguez, M D Caballero, A Gutierrez, et al.
British Journal of Haematology|June 10, 2000
Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patientsJ J Lahuerta, J Martinez-Lopez, J D Serna, et al.
Annals of Hematology|May 25, 2017
Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)A García-Noblejas, J Cannata-Ortiz, E Conde, et al.
Sangre|April 1, 1997
[Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma]J García Laraña, J Díaz Mediavilla, R Martínez, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsJ Bladé, J F San Miguel, M Fontanillas, et al.
British Journal of Haematology|June 10, 2000
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple MyelomaJ J Lahuerta, J Martinez-Lopez, C Grande, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
The European Respiratory Journal|September 7, 2010
Composite anatomical-clinical-molecular prognostic model in non-small cell lung cancerA López-Encuentra, F López-Ríos, E Conde, et al.
Brazilian Journal of Biology = Revista Brasleira De Biologia|August 7, 2013
Addressing key ecological questions to support policy-making in BrazilR M Almeida, V G Pinto, M M Castro, et al.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experienceJ Rodriguez, M D Caballero, A Gutierrez, et al.
British Journal of Haematology|June 10, 2000
Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patientsJ J Lahuerta, J Martinez-Lopez, J D Serna, et al.
Annals of Hematology|May 25, 2017
Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)A García-Noblejas, J Cannata-Ortiz, E Conde, et al.
Sangre|April 1, 1997
[Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma]J García Laraña, J Díaz Mediavilla, R Martínez, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsJ Bladé, J F San Miguel, M Fontanillas, et al.
British Journal of Haematology|June 10, 2000
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple MyelomaJ J Lahuerta, J Martinez-Lopez, C Grande, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Pageof 16